BamSEC and AlphaSense Join Forces
Learn More

Apellis Pharmaceuticals Inc.

NASDAQ: APLS    
Share price (1/8/25): $33.00    
Market cap (1/8/25): $4.105 billion

Underwriting Agreements Filter

EX-1.1
from 8-K 45 pages Sales Agreement
12/34/56
EX-1.1
from 8-K 42 pages Apellis Pharmaceuticals, Inc. 3,174,603 Shares of Common Stock ($0.0001 Par Value Per Share) Pre-Funded Warrants to Purchase 2,380,956 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1.1
from 8-K 40 pages Apellis Pharmaceuticals, Inc. 7,446,809 Shares Common Stock ($0.0001 Par Value Per Share) Underwriting Agreement
12/34/56
EX-1.1
from 8-K 44 pages Open Market Sale Agreementsm
12/34/56
EX-1.1
from 8-K 40 pages Apellis Pharmaceuticals, Inc. 8,750,000 Shares Common Stock ($0.0001 Par Value Per Share) Underwriting Agreement
12/34/56
EX-1.1
from 8-K 40 pages Apellis Pharmaceuticals, Inc. 9,500,000 Shares Common Stock ($0.0001 Par Value Per Share) Underwriting Agreement
12/34/56
EX-1.2
from POS AM 42 pages Apellis Pharmaceuticals, Inc. $150,000,000 Shares Common Stock ($0.0001 Par Value Per Share) Amended and Restated Equity Distribution Agreement
12/34/56
EX-1.1
from 8-K 41 pages Apellis Pharmaceuticals, Inc. 6,000,000 Shares Common Stock ($0.0001 Par Value Per Share) Underwriting Agreement
12/34/56
EX-1.2
from S-3ASR 41 pages Apellis Pharmaceuticals, Inc. $150,000,000 Shares Common Stock ($0.0001 Par Value Per Share) Equity Distribution Agreement
12/34/56
EX-1.1
from S-1 36 pages Apellis Pharmaceuticals, Inc. Shares Common Stock ($0.0001 Par Value Per Share) Underwriting Agreement
12/34/56
EX-1.1
from S-1/A 41 pages Apellis Pharmaceuticals, Inc. Shares Common Stock ($0.0001 Par Value Per Share) Underwriting Agreement
12/34/56